Invention Grant
US08173597B2 Modified recombinant factor VIII and von Willebrand factor and methods of use
有权
修饰重组因子VIII和von Willebrand因子及其使用方法
- Patent Title: Modified recombinant factor VIII and von Willebrand factor and methods of use
- Patent Title (中): 修饰重组因子VIII和von Willebrand因子及其使用方法
-
Application No.: US12267491Application Date: 2008-11-07
-
Publication No.: US08173597B2Publication Date: 2012-05-08
- Inventor: Hans-Peter Schwarz , Peter Turecek
- Applicant: Hans-Peter Schwarz , Peter Turecek
- Applicant Address: US IL Deerfield CH Glattpark (Opfikon)
- Assignee: Baxter International Inc.,Baxter Healthcare S.A.
- Current Assignee: Baxter International Inc.,Baxter Healthcare S.A.
- Current Assignee Address: US IL Deerfield CH Glattpark (Opfikon)
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: A61K38/37
- IPC: A61K38/37 ; C07K14/775
Abstract:
The present invention provides novel methods of increasing the survival of a coagulation protein by inhibiting the interaction with a clearance receptor. The invention also provides methods of preparing compositions that inhibit coagulation protein clearance receptors. Conjugated coagulation proteins, including compositions and formulations thereof, are also provided by the present invention.
Public/Granted literature
- US20090247459A1 MODIFIED RECOMBINANT FACTOR VIII AND VON WILLEBRAND FACTOR AND METHODS OF USE Public/Granted day:2009-10-01
Information query
IPC分类:
